0
Article ? AI-assigned paper type based on the abstract. Classification may not be perfect — flag errors using the feedback button. Tier 2 ? Original research — experimental, observational, or case-control study. Direct primary evidence. Sign in to save

Micro- and nanoplastics and the kidney: exposure pathways, toxicokinetics, and pathophysiological insights

Giornale di Clinica Nefrologica e Dialisi 2026 1 citation ? Citation count from OpenAlex, updated daily. May differ slightly from the publisher's own count.
Marco Lombardi, Franco Bergesio

Summary

Tiny plastic particles from our air, water, and food—called micro- and nanoplastics—can enter our bodies and travel to the kidneys, where studies show they may cause cell damage, inflammation, and scarring over time. This review pulls together existing research on how these plastics get into our system and harm kidney tissue, suggesting that everyday plastic exposure could be an overlooked risk factor for kidney disease. More research is needed, but this is an early signal that reducing plastic exposure might matter for long-term kidney health.

Micro- and nanoplastics (MNPs) are increasingly recognized as pervasive environmental contaminants with major implications for human health. Their ubiquity across air, water, food chains and indoor environments, together with the release of plastic-associated chemicals—including bisphenols, phthalates, PFAS and heavy metals—creates a complex and continuous exposure scenario. MNPs can enter the human body through ingestion, inhalation, dermal contact and medical devices; nanoplastics, in particular, may cross biological barriers, reach the systemic circulation and accumulate in target organs such as the kidney.Experimental evidence identifies multiple mechanisms of nephrotoxicity. MNPs induce oxidative stress, mitochondrial dysfunction, ferroptosis, epithelial barrier disruption, inflammatory activation and tubulo-interstitial fibrosis. Adsorbed contaminants further amplify these effects through endocrine disruption, immunotoxicity and metabolic dysregulation. The detection of MNPs in human kidney tissue and urine supports their systemic bioavailability and renal handling. This review synthesizes current knowledge on environmental and clinical exposure sources, routes of absorption, toxicokinetics and pathogenic pathways of MNP-induced renal injury. Understanding these processes is essential to correctly interpret clinical observations and to recognize MNPs asemerging environmental determinants of kidney health.

Share this paper